EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distribution and inflammatory cell response to intracranial delivery of radioluminescent Y2(SiO4)O:Ce particles

Máté Fischer iD, Amber Zimmerman, Eric Zhang, Joseph Kolis, Ashley Dickey, Mary K Burdette, Praveen Chander, Stephen H Foulger, Jonathan L Brigman, Jason P Weick iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0276819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Máté Fischer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, University of New Mexico HSC, Albuquerque, New Mexico, United States of America. Hauptthemen laut MEDLINE: Brain, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Due to increasing advances in their manufacture and functionalization, nanoparticle-based systems have become a popular tool for in vivo drug delivery and biodetection. Recently, scintillating nanoparticles such as yttrium orthosilicate doped with cerium (Y2(SiO 4 )O:Ce) have come under study for their potential utility in optogenetic applications, as they emit photons upon low levels of stimulation from remote x-ray sources. The utility of such nanoparticles in vivo is hampered by rapid clearance from circulation by the mononuclear phagocytic system, which heavily restricts nanoparticle accumulation at target tissues. Local transcranial injection of nanoparticles may deliver scintillating nanoparticles to highly specific brain regions by circumventing the blood-brain barrier and avoiding phagocytic clearance. Few studies to date have examined the distribution and response to nanoparticles following localized delivery to cerebral cortex, a crucial step in understanding the therapeutic potential of nanoparticle-based biodetection in the brain. Following the synthesis and surface modification of these nanoparticles, two doses (1 and 3 mg/ml) were introduced into mouse secondary motor cortex (M2). This region was chosen as the site for RLP delivery, as it represents a common target for optogenetic manipulations of mouse behavior, and RLPs could eventually serve as an injectable x-ray inducible light delivery system. The spread of particles through the target tissue was assessed 24 hours, 72 hours, and 9 days post-injection. Y2(SiO 4 )O:Ce nanoparticles were found to be detectable in the brain for up to 9 days, initially diffusing through the tissue until 72 hours before achieving partial clearance by the final endpoint. Small transient increases in the presence of IBA-1 + microglia and GFAP + astrocytic cell populations were detected near nanoparticle injection sites of both doses tested 24 hours after surgery. Taken together, these data provide evidence that Y2(SiO 4 )O:Ce nanoparticles coated with BSA can be injected directly into mouse cortex in vivo , where they persist for days and are broadly tolerated, such that they may be potentially utilized for remote x-ray activated stimulation and photon emission for optogenetic experiments in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainNanoparticlesMiceAnimalsBlood-Brain BarrierDrug Delivery SystemsBiological Transport

Autor:innen und Institutionen

  • Department of Neurosciences, University of New Mexico HSC, Albuquerque, New Mexico, United States of America.
  • Department of Materials Science and Engineering, Clemson University, Clemson, South Carolina, United States of America.
  • Center for Optical Materials Science and Engineering Technologies, Clemson University, Clemson, South Carolina, United States of America.
  • Department of Bioengineering, Clemson University, Clemson, South Carolina, United States of America.
  • Center for Brain Recovery and Repair, University of New Mexico HSC, Albuquerque, New Mexico, United States of America.

ORCID-Profile: Máté Fischer, Jason P Weick

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • National Science Foundation
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Fischer, M., Zimmerman, A., Zhang, E., Kolis, J., Dickey, A., Burdette, M. K., Chander, P., Foulger, S. H., Brigman, J. L., & Weick, J. P. (2023). Distribution and inflammatory cell response to intracranial delivery of radioluminescent Y2(SiO4)O:Ce particles. PLOS ONE. https://doi.org/10.1371/journal.pone.0276819

Vancouver

Fischer M, Zimmerman A, Zhang E, Kolis J, Dickey A, Burdette MK, et al. Distribution and inflammatory cell response to intracranial delivery of radioluminescent Y2(SiO4)O:Ce particles. PLOS ONE. 2023. doi:10.1371/journal.pone.0276819

BibTeX
@article{Fischer2023,
  author = {Fischer, Máté and Zimmerman, Amber and Zhang, Eric and Kolis, Joseph and Dickey, Ashley and Burdette, Mary K and Chander, Praveen and Foulger, Stephen H and Brigman, Jonathan L and Weick, Jason P},
  title = {Distribution and inflammatory cell response to intracranial delivery of radioluminescent Y2(SiO4)O:Ce particles},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0276819}
}
Kostenlos starten →